CY1108368T1 - Διαδερμικη συσκευη φελοδιπινης και μεθοδοι - Google Patents

Διαδερμικη συσκευη φελοδιπινης και μεθοδοι

Info

Publication number
CY1108368T1
CY1108368T1 CY20081101041T CY081101041T CY1108368T1 CY 1108368 T1 CY1108368 T1 CY 1108368T1 CY 20081101041 T CY20081101041 T CY 20081101041T CY 081101041 T CY081101041 T CY 081101041T CY 1108368 T1 CY1108368 T1 CY 1108368T1
Authority
CY
Cyprus
Prior art keywords
felodipin
methods
interior device
skin
days
Prior art date
Application number
CY20081101041T
Other languages
English (en)
Inventor
Lino Tavares
Ihor Shevchuk
Mark Alfonso
Geraldine Marcenyac
Kirti H Valia
Original Assignee
Euro-Celtique S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Euro-Celtique S.A. filed Critical Euro-Celtique S.A.
Publication of CY1108368T1 publication Critical patent/CY1108368T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4422—1,4-Dihydropyridines, e.g. nifedipine, nicardipine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Μία μέθοδος για αποτελεσματική αντιμετώπιση υπέρτασης σε ανθρώπους επιτυγχάνεται με χορήγηση φελοδιπίνης μέσω ενός διαδερμικου σκευάσματος. Κατά προτίμηση, το διαδερμικό σκεύασμα εφαρμόζεται στο δέρμα του ασθενούς και διατηρείται σε επαφή με το δέρμα για τουλάχιστον περίπου 24 ώρες ημέρες, και κατά προτίμηση για περίπου 3 έως περίπου 8 ημέρες.
CY20081101041T 2000-10-23 2008-09-24 Διαδερμικη συσκευη φελοδιπινης και μεθοδοι CY1108368T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US24251400P 2000-10-23 2000-10-23
EP01988573A EP1328273B1 (en) 2000-10-23 2001-10-23 Felodipine transdermal device and methods

Publications (1)

Publication Number Publication Date
CY1108368T1 true CY1108368T1 (el) 2014-02-12

Family

ID=22915068

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20081101041T CY1108368T1 (el) 2000-10-23 2008-09-24 Διαδερμικη συσκευη φελοδιπινης και μεθοδοι

Country Status (9)

Country Link
EP (1) EP1328273B1 (el)
AT (1) ATE399551T1 (el)
AU (1) AU2002232755A1 (el)
CY (1) CY1108368T1 (el)
DE (1) DE60134656D1 (el)
DK (1) DK1328273T3 (el)
ES (1) ES2309107T3 (el)
PT (1) PT1328273E (el)
WO (1) WO2002034206A2 (el)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10305137A1 (de) * 2003-02-07 2004-08-26 Novosis Ag Transdermale therapeutische Abgabesysteme mit einem Butenolid
ATE437634T1 (de) * 2004-01-14 2009-08-15 Lavipharm Lab Inc Transdermale abgabevorrichtung für dihydropyridin-artige calcium-antagonisten mit 2 fettsäuren

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU3245493A (en) * 1991-12-02 1993-06-28 Sepracor, Inc. Methods and compositions for treating hypertension, angina, and other disorders using optically pure s(-) felodipine
US5882676A (en) * 1995-05-26 1999-03-16 Alza Corporation Skin permeation enhancer compositions using acyl lactylates
US5968547A (en) * 1997-02-24 1999-10-19 Euro-Celtique, S.A. Method of providing sustained analgesia with buprenorphine
AR022471A1 (es) * 1999-02-02 2002-09-04 Ortho Mcneil Pharm Inc Metodo para la fabricacion de matrices transdermicas

Also Published As

Publication number Publication date
PT1328273E (pt) 2008-09-23
EP1328273A4 (en) 2004-09-22
WO2002034206A2 (en) 2002-05-02
EP1328273A2 (en) 2003-07-23
ES2309107T3 (es) 2008-12-16
AU2002232755A1 (en) 2002-05-06
DE60134656D1 (de) 2008-08-14
ATE399551T1 (de) 2008-07-15
EP1328273B1 (en) 2008-07-02
WO2002034206A9 (en) 2003-04-17
DK1328273T3 (da) 2008-10-20
WO2002034206A3 (en) 2002-07-18

Similar Documents

Publication Publication Date Title
DK1316308T3 (da) Transdermalt terapeutisk plaster med capsaicin og capsaicin-analoger
DE69017654T2 (de) Äusserlich anzuwendende analgetische lotion und verfahren zur herstellung.
ATE202923T1 (de) Orale dosierungsform und verfahren zur behandlung von schmerzzuständen in dermundhöhle
DE60115842D1 (de) Ventilanordnung
HUP9904023A2 (hu) Leptin antagonisták alkalmazása inzulin rezisztencia kezelésére II. típusú cukorbajban
DE60305488D1 (de) Gerät zum behandeln der haut eines menschen
ES2166783T3 (es) Factor viii activado utilizado como agente terapeutico y metodo para el tratamiento de la deficiencia de factor viii.
SE9404196D0 (sv) New antithrombotic formulation
DE69116380D1 (de) Pharmazeutische zubereitung zur behandlung verlängerter gerinnungszeit
DE60124715D1 (de) Er produktion von beta-endorphin
IL138290A0 (en) Use of selegiline or desmethylselegiline for treating wounds, burns and dermatological damage
CY1108368T1 (el) Διαδερμικη συσκευη φελοδιπινης και μεθοδοι
WO2002054996A3 (en) Terazosin transdermal device and methods
PT1063978E (pt) Metodo de tratamento de dor de neuroma
DE69734349D1 (de) Behandlung von knochenleiden mit adrenomedullin
NO960866L (no) Fremgangsmåte til behandling av leversykdom og lignende indikasjoner med vasodilaterende midler
UA67319A (en) Method for surgical treatment of lymphedema in limb
TNSN03022A1 (en) Method for treatment of inflammation
UA28769A (uk) Спосіб лікування променевих ушкоджень шкіри
UA69760A (en) Method for topical treatment of demodecosis
UA51365A (uk) Спосіб лікування больового синдрому в ампутаційній куксі
UA40330A (uk) Спосіб лікування запальних захворювань пародонту